A Study on Drug Utilization Pattern of Antihypertensive Drugs in Patients with Diabetes Mellitus
DOI:
https://doi.org/10.37506/gyac9s27Keywords:
Diabetes Mellitus, Hypertension, Drug utilizationAbstract
Background: Both hypertension and diabetes mellitus encompass a major chunk of the disease burden in the world. Co-existence of hypertension with diabetes escalates the further development of associated complications. Treatment of hypertension, therefore, would prevent progression of diabetes itself or vice-versa. This study aims to describe the utilization pattern of antihypertensive drugs in diabetic individuals.
Methods: This was a hospital based prospective observational study carried out in the department of Medicine of a tertiary care teaching hospital of upper Assam over one year. Diabetic hypertensive patients visiting the department of Medicine were included in the study. Prescriptions, outpatient and inpatient records were the study materials. The assessment tools used were WHO Core indicators, index system for comprehensive appraisal of medical care, index of rational drug prescribing.
Conclusion: Majority of patients (78.1%) were above 44 years. Of the 104 patients, 54% were male and 46% were female. Average number of drugs per prescription was 4.3. The most prescribed antihypertensive drug was telmisartan followed by the combination of telmisartan and amlodipine. Among the 68 patients prescribed monotherapy, ARB (Angiotensin receptor blocker) was highest prescribed. ARB and CCB (calcium channel blocker) the most frequent polytherapy. As monotherapy CCB was most prescribed to patients without complications while ARB to those with complications. Rational utilization of drugs were observed. The antihypertensive drugs were prescribed at par with the existing guidelines.
References
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014 Jan; 37(1): S81-S90.
International Diabetes Federation. IDF diabetes atlas. 9th ed. International Diabetes Federation;2019.
World Health Organization. Global Report on Diabetes. France: WHO press; 2016. 88p.
World Health Organization. (1999). Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus. World Health Organization.
Piette JD, Kerr EA. The Impact of Comorbid Chronic Conditions on Diabetes Care. Diabetes Care. 2006 Mar; 29 (3): 725-731.
James PA, Oparil S, Carter BL, Cushman WC, Himmelfarb CD, Handler J et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311(5): 507–520.
Swami SS, Swami SC, Patil VW, Kanhere AM. Hypertension and diabetes in India: a review. Int J Clin Biochem Res. 2015;2(1):54-58.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger EZD, Hahn EJ, Himmelfarb CD et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140: e596–e646.
McCormack T, Boffa RJ, Jones NR, Carville S, McManus RJ. The 2018 ESC/ESH hypertension guideline and the 2019 NICE hypertension guideline, how and why they differ. Eur Heart J. 2019; 40(42): 3456-58.
Shah SN, Munjal YP, Kamath SA, Mehta N, Mukherjee S, Kirpalani A, Gupta P, Shah H, Rohatgi R, Billimoria AR, Maiya M, Das MK, Goswami KC, Sharma R, Rajapurkar MA, Chawla R, Saboo B, Jha V. Indian guidelines on hypertension-IV (2019). J Hum Hypertens. 2020 May: 1-14.
Solanki KC, Mistry RA, Singh AP, Jadav SP, Patel NM, Trivedi HR. Drug utilization study of anti-hypertensive drugs and their adverse effects in patients of a tertiary care hospital. J Clin Exp Res. 2013 Sept- Dec; 1(3): 58-67.
Ragam AS, Acharya S, Holla R. Assessment of drug use pattern using World Health Organization prescribing indicators in a tertiary care hospital in Mangalore: A cross-sectional study. Natl J Physiol Pharm Pharmacol [Internet]. 2017 May 13[cited 2020 May 6]; 7(10):1026-30.
Atif M, Sarwar MR, Azeem M, Naz M, Amir S, Nazir K. Assessment of core drug use indicators using WHO/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan. BMC Health Serv Res. 2016 Dec 08; 16: 684.
Dong L, Yan H, Wang D. Drug prescribing indicators in village health clinics across 10 provinces of Western China. Fam Pract. 2011 Feb; 28(1):63-7.
Mahmood A, Elnour AA, Ali AAA, Hassan NAGM, Shehab A, Bhagavathula AS. Evaluation of rational use of medicines (RUM) in four government hospitals in UAE. Saudi Pharm J. 2016 Mar; 24(2): 189-96.
Passarella P, Kiseleva TA, Valeeva FV, Gosmanov AR. Hypertension management in diabetes:2018 update. Diabetes Spectre. 2018 Aug; 31(3): 218-224.
Sachdev Y. Clinical Endocrinology and Diabetes Mellitus. Volume 2. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2008. Chapter 26.2, Management of diabetes mellitus; p.927-43.
Dhanaraj E, Raval A, Yadav R, Bhansali A and Tiwari P. Prescription pattern of antihypertensive agents in T2DM patients visiting tertiary care centre in North India. Int J of Hypertens. 2012 Aug; 2012: 520915.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Prapti Bhuyan, Meghali Chaliha, Usha Rani Pegu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.